SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System

计划入组 337 人 · 首次发布于 2015 年 5 月 12 日

Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation

计划入组 1,000 人 · 首次发布于 2025 年 9 月 16 日

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

计划入组 1,899 人 · 首次发布于 2022 年 1 月 20 日

RDN-929

RDN-009

RDN-18002

Medtronic

United States

Catheter Precision

United States

GRADIENT DENERVATION TECHNOLOGIES

France

Medtronic's Symplicity Spyral RDN Catheter Receives CMS Transitional Pass-Through Payment

Medtronic Gains Japanese Approval for Symplicity Spyral Renal Denervation System to Treat Resistant Hypertension

Medicare Reimbursement Approved for Medtronic and Recor Medical Renal Denervation Technologies